NeoGenomics Inc (NEO)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands -88,164 -88,337 -91,335 -100,832 -103,052 -109,325 -124,640 -134,448 -156,087 -172,807 -173,010 -155,675 -118,754 -71,648 -27,266 -23,806 -13,992 -17,210 -18,220 5,165
Revenue (ttm) US$ in thousands 660,566 644,118 628,248 610,663 591,643 574,796 551,624 529,779 509,728 496,755 489,313 485,965 484,329 484,594 488,698 453,951 444,448 425,319 404,547 419,283
Operating profit margin -13.35% -13.71% -14.54% -16.51% -17.42% -19.02% -22.60% -25.38% -30.62% -34.79% -35.36% -32.03% -24.52% -14.79% -5.58% -5.24% -3.15% -4.05% -4.50% 1.23%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-88,164K ÷ $660,566K
= -13.35%

The operating profit margin of NeoGenomics Inc has experienced a steady decline over the past few years, starting from 1.23% as of March 31, 2020, and reaching a low of -35.36% as of June 30, 2022. This downward trend continued until December 31, 2024, when the operating profit margin improved slightly to -13.35%.

A negative operating profit margin indicates that the company's operating expenses exceed its gross profit, resulting in operating losses. The significant decrease in the operating profit margin over the observed period may suggest challenges in controlling operating costs, pricing pressures, or inefficiencies in the company's operations.

The management of NeoGenomics Inc may need to closely evaluate and address the factors contributing to the declining operating profit margin to improve overall profitability and ensure sustainable business operations in the future.